ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharmacology developmental biology disease medicine

Diverse Pharmacological Modulators
AMSbio | Aug 31, 2015 | 1 min read
For Targets, Pathways and Processes
Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014 | 2 min read
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
Image of the tissue surrounding a pancreatic tumor thickening and scarring.
How Pancreas Injuries Can Cause Cancer in Mice
Dan Robitzski | Nov 9, 2021 | 4 min read
A key mutation turns healing cells into cancer promoters.
Albert Einstein College of Medicine
The Scientist Staff | Nov 21, 2004 | 4 min read
Next year marks the 50th anniversary of the opening of the Albert Einstein College of Medicine of Yeshiva University.
List Of New IoM Members
Edward Silverman | Nov 26, 1995 | 5 min read
William G. Baxt, professor and chairman, department of emergency medicine, University of Pennsylvania School of Medicine; chief, emergency services, Hospital of the University of Pennsylvania Arthur L. Beaudet, investigator, Howard Hughes Medical Institute, and professor and acting chairman, department of molecular and human genetics, Baylor College of Medicine Helen M. Blau, professor, department of molecular pharmacology, Stanford University School of Medicine Murray F. Brennan, chairm
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
The AIDS Research Evaluators
Lynn Gambale | Jul 9, 1995 | 6 min read
Chairman: Arnold Levine, chairman, department of molecular biology, Princeton University Barry Bloom, Weinstock Professor and Howard Hughes Medical Institute (HHMI) investigator, department of microbiology and immunology, Albert Einstein College of Medicine, New York Rebecca Buckley, professor of pediatrics and immunology, Duke University Medical Center Charles Carpenter, chairman, Office of AIDS Research Advisory Committee; professor of medicine,Brown University School of Medicine Don
An Orphan Disease Gets Adopted
Steve Bunk | Nov 12, 2000 | 7 min read
Courtesy of Ed Rowton, Walter Reed Army Institute of Research An anopheline mosquito taking a blood meal. Researchers and physicians, open your guides to rare diseases, for that may be the only place you'll encounter Jumping Frenchmen of Maine. There you also will find Kabuki Make-up Syndrome, Split-Hand Deformity, Stiff Person Syndrome, Tangier Disease, and Twin-Twin Transfusion Syndrome. These are among thousands of "orphan diseases," originally so called because they weren't "adopted" by spon
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy

Run a Search

ADVERTISEMENT